Table 5 Summary of Oncologic outcomes
From: Meta-analysis of subxiphoid approach versus lateral approach for thoracoscopic Thymectomy
| Â | SVATS | LVATS | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Study | Thymoma | Tumor diameter (cm) | Masaoka staging | MG | Carcinoma | Thymoma | Tumor diameter (cm) | Masaoka staging | MG | Carcinoma |
Suda Takashi | 11/46 | NA | Stage I and II | 11/46 | 0/46 | 27/35 | NA | Stage I and II | 10/35 | 0/35 |
Hsu C-P | 4/11 | ≤4 cm | Stage I and II | 15/15 | 0/15 | 2/10 | ≤4 cm | Stage I and II | 12/12 | 0/12 |
Wang, H | 36/36 | NA | Stage I and II | 0/36 | NA | 47/47 | NA | Stage I and II | 0/47 | NA |
Yano Motoki | 7/14 | 4.5 ± 2.7 | NA | 1/14 | 2/14 | 26/46 | NA | NA | 2/46 | 2/46 |
Lu Qiang | 10/31 | ≤5 cm | Stage I and II | 41/41 | 0/41 | 12/24 | ≤5 cm | Stage I and II | 36/36 | 0/36 |
Zhang Louqian | 28/28 | 3.2 ± 1.6 | Stage I and II | 0/28 | NA | 70/70 | 3.6 ± 1.3 | Stage I and II | 0/70 | NA |
Yong Tang | NA | NA | NA | 20/20 | NA | 25 | NA | NA | 25/25 | NA |